Related Experiment Video
Updated: Jun 13, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Forward genetic screening in engineered colorectal cancer organoids identifies regulators of metastasis
Xin Wang1, Zvi Cramer1, Nicolae Adrian Leu1
1Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Abstract:
Metastatic outgrowth requires that cancer cells delaminate from the primary tumor, intravasate, survive in circulation, extravasate, migrate to, and proliferate at a distal site. Recurrent genetic drivers of metastasis remain elusive, suggesting that unlike the early steps of oncogenesis, metastasis drivers may be variable. We develop a framework for identifying metastasis regulators using CRISPR/Cas9-based screening in a genetically defined organoid model of colorectal adenocarcinoma. We conduct in vitro screens for invasion and migration alongside orthotopic, in vivo screens for gain of metastasis in a syngeneic mouse model. We identify CTNNA1 and BCL2L13 as bona fide metastasis-specific suppressors which do not confer any selective advantage in primary tumors. CTNNA1 loss promotes cell invasion and migration, and BCL2L13 loss promotes anchorage-independent survival and non-cell-autonomous changes to macrophage polarization. This study demonstrates proof of principle that large-scale genetic screening can be performed in tumor-organoid models in vivo and identifies novel regulators of metastasis.
Insights
Researchers identified CTNNA1 and BCL2L13 as key suppressors of metastasis in colorectal cancer. Their loss promotes cancer cell spread and survival, highlighting new therapeutic targets for metastatic disease.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Metastatic outgrowth is a complex process involving multiple steps, from primary tumor cell detachment to distal site proliferation.
- Identifying genetic drivers of metastasis is challenging due to their potential variability compared to early oncogenesis drivers.
Purpose of the Study:
- To develop and apply a screening framework for identifying metastasis regulators.
- To discover novel metastasis-specific suppressors in colorectal adenocarcinoma using genetic screening.
Main Methods:
- Utilized CRISPR/Cas9-based screening in a genetically defined organoid model of colorectal adenocarcinoma.
- Conducted in vitro screens for invasion and migration.
- Performed orthotopic, in vivo screens for metastasis in a syngeneic mouse model.
Main Results:
- Identified CTNNA1 (Cadherin 1) and BCL2L13 (BCL2 Like 13) as metastasis-specific suppressors.
- Demonstrated that loss of CTNNA1 enhances cell invasion and migration.
- Showed that loss of BCL2L13 promotes anchorage-independent survival and alters macrophage polarization.
Conclusions:
- CTNNA1 and BCL2L13 are novel regulators that specifically suppress metastasis without affecting primary tumor growth.
- Validated the utility of tumor-organoid models for large-scale in vivo genetic screening.
- Established a framework for identifying metastasis regulators with potential therapeutic implications.
More Related Videos
09:16High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor
Published on: June 14, 2018
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
Related Concept Videos
Gene Conversion
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...